Clinical Features and Outcomes of Paediatric Spitz-type Lesions

D. Patel,R. Chawla,AJK. Patel
DOI: https://doi.org/10.1016/j.bjps.2024.07.031
IF: 3.022
2024-07-29
Journal of Plastic Reconstructive & Aesthetic Surgery
Abstract:Introduction and Objectives No definitive management guidelines exist for Spitz-type lesions; recommendations in the UK favour a "safe" approach, with a low threshold for excision. We aim to describe Spitz-type lesions in children to further clarify clinical features and outcomes. Methods We conducted a retrospective cohort study in Addenbrooke's Hospital, Cambridge, UK, reviewing all patients with age ≤18 years with histologically confirmed Spitz-type lesions from November 2014-September 2020. Information collected included patient demographics, lesion details, follow-up, outcomes, and recurrence. Results 91 children (male:female 42:49, mean age at diagnosis: 9.4 years, SD: 4.6 years) were identified, consisting of 64 (70.3%) Classic Spitz or Spitzoid naevi, 26 (28.6%) Atypical Spitz Tumours (AST), and one (1.1%) Spitzoid malignant melanoma based on histological features. Assessing clinical features where documented, we found 22.0% (20/91) showed amelanosis, 44.0% (40/91) had a raised bump, 12.1% (11/91) displayed bleeding, 25.0% (20/80) had non-uniform colour, 96.7% (88/91) were de novo lesions, 55.1% (43/78) were evolving in size, and 35.9% (28/78) were evolving in colour. 59 patients (64.8%) were discharged without requiring follow-up, and the other 32 had a median follow-up time of 4 months. We have found no incidences of local recurrence after confirmed excision, no distant metastases, and no mortality in all patients to date. Conclusions Outcomes for paediatric Spitz-type lesions continue to be exceptionally good, remaining a low-risk lesion which is more likely to be benign in children. Hence, we do not advocate aggressive management policies for paediatric patients with clinically banal Spitz-type lesions.
surgery
What problem does this paper attempt to address?